RecallHawk

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUD...

ACELLA

Summary

FDA approved BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE) by ACELLA. ANDA (Generic) approval (Labeling) on 2022-10-27. SYRUP, ORAL.

Details

Source

Drug Approval

External ID

ANDA203375-5

Action Date

2022-10-27

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE (generic: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE), SYRUP, ORAL. Application: ANDA203375

Company

Context & Analysis

Frequently Asked Questions

How often does ACELLA have FDA actions?

This is the only FDA action we have on record for ACELLA in our database.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA203375-5" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions